HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Paul, S. Articles by Solomon, A. Search for Related Content PubMed PubMed Citation Articles by Paul, S. Articles by Solomon, A. Social Bookmarking                      What's this?

Volume 270, Number 25, Issue of June 23, pp. 15257-15261, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Natural Catalytic Antibodies: Peptide-hydrolyzing Activities of Bence Jones Proteins and V Fragment

Sudhir Paul , Lan Li , Ravishankar Kalaga , Priscilla Wilkins-Stevens , Fred J. Stevens , Alan Solomon

Monoclonal human light chains, i.e. Bence Jones proteins, and their recombinant variable fragments (V) were screened for proteolytic activity using peptide-methylcoumarinamide (peptide-MCA) conjugates and vasoactive intestinal polypeptide (VIP) as substrates. Sixteen of 21 Bence Jones proteins and one of three V fragments were capable of detectable cleavage of one or more substrates. The magnitude and kinetic characteristics of the activity varied with different substrates. Among the peptide-MCA substrates, the presence of tripeptide or tetrapeptide moieties with a basic residue at the scissile bond generally favored expression of the activity. The influence of N-terminal flanking residue recognition was evident from differing values of K and k (turnover number) observed using different Arg-containing peptide-MCA substrates. Different light chains displayed different kinetic parameters for the same substrate, suggesting unique catalytic sites. Hydrolysis of VIP was characterized by nanomolar Michaelis-Menten constants (K), suggesting comparatively high affinity recognition of this peptide. The 25-kDa monomer and the 50-kDa dimer forms of one light chain preparation were resolved by gel filtration in 6 M guanidine hydrochloride. Following renaturation, the monomer displayed 51-fold greater peptide-MCA-hydrolyzing activity than the dimer. A renatured V domain prepared by gel filtration in 6 M guanidine hydrochloride displayed VIP-hydrolyzing activity in the 12.5-kDa peak fractions. These results provide evidence for the proteolytic activity of certain human light chains and imply that this phenomenon may have a pathophysiological significance.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				B. Wootla, S. Dasgupta, J. D. Dimitrov, J. Bayry, H. Levesque, J.-Y. Borg, A. Borel-Derlon, D. N. Rao, A. Friboulet, S. V. Kaveri, et al. Factor VIII Hydrolysis Mediated by Anti-Factor VIII Autoantibodies in Acquired Hemophilia J. Immunol., June 1, 2008; 180(11): 7714 - 7720. [Abstract] [Full Text] [PDF]

				Y.-R. Kim, J.-S. Kim, S.-H. Lee, W.-R. Lee, J.-N. Sohn, Y.-C. Chung, H.-K. Shim, S.-C. Lee, M.-H. Kwon, and Y.-S. Kim Heavy and Light Chain Variable Single Domains of an Anti-DNA Binding Antibody Hydrolyze Both Double- and Single-stranded DNAs without Sequence Specificity J. Biol. Chem., June 2, 2006; 281(22): 15287 - 15295. [Abstract] [Full Text] [PDF]

				S. Lacroix-Desmazes, J. Bayry, S. V. Kaveri, D. Hayon-Sonsino, N. Thorenoor, J. Charpentier, C.-E. Luyt, J.-P. Mira, V. Nagaraja, M. D. Kazatchkine, et al. From the Cover: High levels of catalytic antibodies correlate with favorable outcome in sepsis PNAS, March 15, 2005; 102(11): 4109 - 4113. [Abstract] [Full Text] [PDF]

				S. Planque, Y. Bangale, X.-T. Song, S. Karle, H. Taguchi, B. Poindexter, R. Bick, A. Edmundson, Y. Nishiyama, and S. Paul Ontogeny of Proteolytic Immunity: IgM SERINE PROTEASES J. Biol. Chem., April 2, 2004; 279(14): 14024 - 14032. [Abstract] [Full Text] [PDF]

				H. DEBAT, B. AVALLE, O. CHOSE, C.-O. SARDE, A. FRIBOULET, and D. THOMAS Overpassing an aberrant V{kappa} gene to sequence an anti-idiotypic abzyme with {beta}-lactamase-like activity that could have a linkage with autoimmune diseases FASEB J, March 1, 2001; 15(3): 815 - 822. [Abstract] [Full Text] [PDF]

				S. Paul, A. Tramontano, G. Gololobov, Y.-X. Zhou, H. Taguchi, S. Karle, Y. Nishiyama, S. Planque, and S. George Phosphonate Ester Probes for Proteolytic Antibodies J. Biol. Chem., July 20, 2001; 276(30): 28314 - 28320. [Abstract] [Full Text] [PDF]